Clearmind Medicine Announces Evaluation of its Psychedelic-Based Treatment (MEAI) for Potential FDA Breakthrough Therapy Designation

Conscientia Health Launches Virtual Primary Care Services - A Groundbreaking Breakthrough in AI-Powered Integrative Telehealth Uniting...

Wheat Tortilla and Wraps Market to Cross $22.19 Billion by 2031, Fuelled by Rising popularity of Mexican Cusines: New Industry Research by...

New Research Reveals The Hidden Leadership Crisis Hiding In Plain Sight: 54% Of Leaders Are Producing Anxiety, Drift, And Disengagement –...

AZIO AI Corporation Expands Supplier Ecosystem, Secures Authorized Partnership with Giga Computing to Enhance Scalable AI Infrastructure...

BriaCell Announces Six Clinical Data Presentations at ASCO 2026

Velo3D, Inc. Announces Pricing of $50 Million Underwritten Registered Direct Offering of Common Stock

Tovecimig Demonstrates Statistically Significant Benefit in COMPANION-002 Randomized Phase 2/3 Study in Patients with Biliary Tract Cancer

ADC Therapeutics to Host First Quarter 2026 Financial Results Conference Call on May 4, 2026

NIMA’s Next-Gen Portable Gluten Sensor Wins Gold Stevie® Award for Achievement in Product Innovation

BioMarin to Host First Quarter 2026 Financial Results Conference Call and Webcast on Monday, May 4, 2026, at 4:30pm ET

Medicus Pharma CEO meets with lawmakers on Energy & Commerce Committee on Capitol Hill

Vision Marine Technologies Secures Conditional TSX Venture Exchange Listing Approval, Expanding Capital Markets Access for Its Marine...

Weight Watchers Announces Actions to Utilize Up to $40 million to Pay Down Debt

KUSTOM ENTERTAINMENT TO HIGHLIGHT STRATEGIC PROGRESS AT THE 16th ANNUAL LD MICRO INVITATIONAL

HCW Biologics Delivers a Major Update for its T-Cell Engager Program Revealing Mechanism of Action and Validating Tissue Factor as Target...

NervGen Pharma Strengthens Leadership Team with Appointment of Keith Vendola as Chief Financial Officer

urban-gro, Inc. (Nasdaq: UGRO) Issues Comprehensive Business Update: Strategic Transformation from Controlled Environment Agriculture to...

Greenlane Holdings Regains Compliance with Nasdaq Minimum Bid Price Requirement

CorMedix Therapeutics Announces Positive Topline Results from Phase III ReSPECT Trial Assessing REZZAYO® for the Prophylaxis of Invasive...